Drugs / Ze 91019
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05684523 | Mar → Dec 2023 | cognitive disorder, sleep-wake disorder | Max Zeller Soehne AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ze 91019 | “This study evaluated the feasibility of investigating the effect of a valerian and hops-based herbal medication (Ze 91019) on daytime cognitive performance, psychological...” PMID 40462685 ↗ Jun 2025 |
| Modality | Traditional medicine (herbal / TCM) | “herbal drug” NCT05684523 ↗ |